Ritonavir Unknown Status Phase 4 Trials for Hepatitis C Viral Infection / Human Immunodeficiency Virus (HIV) Infections Treatment

Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01105611Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users
NCT01045369A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects
NCT01049685Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy
NCT00885664Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection
NCT00759070Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism
NCT00005017Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment